# Confirmatory Study 3 of KPS-0373 in Patients With Spinocerebellar Degeneration

> **NCT07040137** · PHASE3 · RECRUITING · sponsor: **Kissei Pharmaceutical Co., Ltd.** · enrollment: 142 (estimated)

## Conditions studied

- Spinocerebellar Degeneration

## Interventions

- **DRUG:** KPS-0373
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07040137
- **Lead sponsor:** Kissei Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-07
- **Primary completion:** 2027-03-31
- **Final completion:** 2027-03-31
- **Target enrollment:** 142 (ESTIMATED)
- **Last updated:** 2025-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07040137

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07040137, "Confirmatory Study 3 of KPS-0373 in Patients With Spinocerebellar Degeneration". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07040137. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*